介入性腫瘤學市場規模、佔有率、成長分析（按產品類型、按手術類型、按癌症類型、按最終用戶、按地區）- 產業預測 2025-2032

預計 2023 年全球介入性腫瘤學市場規模將達到 27.5 億美元，並從 2024 年的 30 億美元成長到 2032 年的 60.2 億美元，預測期內（2025-2032 年）的複合年成長率為 9.1%。

介入性腫瘤學是癌症治療領域中一個新興且快速發展的領域，它利用微創技術和先進的影像引導技術（如 CT、超音波、MRI 和 X 光）來診斷和治療癌症。這種創新方法可以使用切片穿刺針、消融電極和血管內導管等專門儀器精確瞄準腫瘤，即使在難以到達的位置。介入性腫瘤學與手術和放射等傳統治療方法相結合，提供有針對性的治療，旨在緩解癌症症狀，同時減少侵入性手術的需要。此外，介入性腫瘤科醫師擅長進行內視鏡檢查和大腸鏡檢查，以治療各種癌症，包括肝癌、腎癌、肺癌、乳癌、攝護腺癌和轉移性腫瘤，最終改善患者的治療效果。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

介入性腫瘤學市場規模（依產品類型和複合年成長率）（2025-2032）

• 市場概覽
• 消融設備
  • 射頻消融設備
  • 微波消融裝置
  • 冷凍消融裝置
  • 不可逆電穿孔裝置
  • 高強度聚焦超音波（HIFU）系統
• 栓塞裝置
  • 放射栓塞裝置（Y-90微球）
  • 經動脈栓塞化療（TACE）藥物
  • 藥物釋放型珠（DEB）
  • 非藥物釋放型珠
• 支援的設備
  • 微導管
  • 導管導引線
  • 針刺（切片檢查、消融）
  • 導管鞘套和鞘套
  • 影像造影顯影劑
• 其他
  • 機器人輔助系統
  • 規劃導航軟體平台

介入性腫瘤學市場規模（依手術類型和複合年成長率） (2025-2032)

• 市場概覽
• 熱燒蝕
• 非熱消融
• 栓塞治療
• 椎體成形術和骨水泥成形術
• 切片檢查和腫瘤標記程序

介入性腫瘤學市場規模（依癌症類型和複合年成長率）（2025-2032）

• 市場概覽
• 肝癌
• 肺癌
• 腎癌
• 骨轉移
• 乳癌
• 攝護腺癌
• 胰臟癌
• 大腸直腸癌
• 其他

介入性腫瘤學市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概覽
• 醫院
• 門診手術中心（ASC）
• 癌症研究中心
• 介入放射科診所

介入性腫瘤學市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Boston Scientific Corporation-USA
• Medtronic plc-Ireland
• Siemens Healthineers-Germany
• Terumo Corporation-Japan
• Becton, Dickinson and Company（BD）-USA
• Merit Medical Systems-USA
• AngioDynamics, Inc.-USA
• ALPINION MEDICAL SYSTEMS-South Korea
• ATRICURE, INC.-USA
• EndoShape, Inc.-USA
• ABK Biomedical Inc.-Canada
• Cook Medical Inc.-USA
• Sirtex Medical Limited-Australia
• BTG International Ltd.-UK
• Hologic, Inc.-USA
• Canon Medical Systems Corporation-Japan
• GE Healthcare-USA
• Philips Healthcare-Netherlands

結論和建議

Global Interventional Oncology Market size was valued at USD 2.75 billion in 2023 and is poised to grow from USD 3.0 billion in 2024 to USD 6.02 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

Interventional oncology is an emerging and rapidly growing field in cancer care, leveraging minimally invasive techniques and advanced image guidance technologies, such as CT, ultrasound, MRI, and X-rays, to diagnose and treat cancer. This innovative approach allows for precise targeting of tumors, even in difficult-to-reach areas, using specialized instruments like biopsy needles, ablation electrodes, and intravascular catheters. As a key component alongside traditional therapies such as surgery and radiation, interventional oncology provides focused treatments that aim to reduce the need for invasive procedures while alleviating cancer symptoms. Additionally, interventional oncologists are skilled in conducting endoscopies and colonoscopies, addressing various cancers, including liver, kidney, lung, breast, prostate, and metastatic tumors, ultimately improving patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Oncology Market Segments Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Interventional Oncology Market

The rising global incidence of cancer serves as a major catalyst for the interventional oncology market. As the population ages and lifestyle-related risk factors contribute to higher cancer rates, there is an increasing need for effective treatments. This growing demand encourages healthcare providers to implement cutting-edge interventional techniques that not only improve patient outcomes but also enhance survival rates. Consequently, the market is witnessing significant innovation and expansion driven by the urgent requirement for advanced cancer care solutions tailored to meet the needs of patients worldwide. This momentum is likely to continue as the challenge of cancer persists.

Restraints in the Global Interventional Oncology Market

A significant challenge facing the Global Interventional Oncology market is the limited awareness and training regarding interventional oncology techniques among healthcare professionals. Many practitioners lack familiarity with the newest innovations and procedures, which can result in their underutilization. This gap in knowledge can hinder the market's growth potential. Furthermore, the necessity for specialized training may impede the swift adoption of advanced technologies across different healthcare environments. As healthcare providers navigate these challenges, the overall progress in integrating interventional oncology practices may be delayed, ultimately affecting the market's expansion and evolution in an increasingly competitive landscape.

Market Trends of the Global Interventional Oncology Market

The Global Interventional Oncology market is witnessing a profound shift towards minimally invasive techniques, propelled by the dual benefits of reduced recovery times and minimized complications for patients. This trend is gaining traction as both patients and healthcare professionals increasingly prefer these innovative methods, which are designed to improve treatment outcomes. Furthermore, advancements in technology, such as enhanced imaging modalities and precision-guided interventions, are being rapidly integrated into clinical practice, thus elevating the efficacy and safety of oncological procedures. This evolution not only reflects a broader movement towards patient-centered care but also positions minimally invasive interventional oncology as a key growth driver in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Interventional Oncology Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Ablation Devices
  • Radiofrequency (RF) Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Irreversible Electroporation Devices
  • High-Intensity Focused Ultrasound (HIFU) Systems
• Embolization Devices
  • Radioembolization Devices (Y-90 Microspheres)
  • Transarterial Chemoembolization (TACE) Agents
  • Drug-Eluting Beads (DEBs)
  • Non-drug-eluting Beads
• Support Devices
  • Microcatheters
  • Guidewires
  • Needles (biopsy, ablation)
  • Introducers and Sheaths
  • Imaging Contrast Agents
• Others
  • Robotic Assistance Systems
  • Software Platforms for Planning and Navigation

Global Interventional Oncology Market Size by Procedure Type & CAGR (2025-2032)

• Market Overview
• Thermal Ablation
• Non-thermal Ablation
• Embolization Procedures
• Vertebroplasty & Cementoplasty
• Biopsy and Tumor Marking Procedures

Global Interventional Oncology Market Size by Cancer Type & CAGR (2025-2032)

• Market Overview
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastases
• Breast Cancer
• Prostate Cancer
• Pancreatic Cancer
• Colorectal Cancer
• Others

Global Interventional Oncology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cancer Research Centers
• Interventional Radiology Clinics

Global Interventional Oncology Market Size & CAGR (2025-2032)

• North America (Product Type, Procedure Type, Cancer Type, End User)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Cancer Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Cancer Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Cancer Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Cancer Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALPINION MEDICAL SYSTEMS - South Korea
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATRICURE, INC. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoShape, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABK Biomedical Inc. - Canada
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical Limited - Australia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTG International Ltd. - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare - Netherlands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations